MTOR and breast carcinoma: In addition, breast cancer development includes genetic variations of p53, modified by the angiogenic pathway (VEGF) and mTOR-related signaling pathway, and proapoptotic protein such as Bax correlated with the increased formation of antiapoptotic protein Bcl2 and proliferating cell nuclear antigen (PCNA) [46, 47].